Privi Speciality Chemicals Ltd
Privi Speciality Chemicals Ltd (PRIVISCL) last reported results for the quarter ended Jun 2026, with sales of ₹666 crore and net profit of ₹83 crore. The next scheduled event is a merger acquisition on 27 Oct 2026. The stock last traded at ₹3,434, a market capitalisation of ₹13,416 crore, on a P/E of 38.4. Over the past 52 weeks the stock has ranged between ₹2,406 and ₹3,785. Figures are as of 6 Oct 2026 and are not real time.
Privi Speciality Chemicals Ltd share price and key metrics
- Current price
- ₹3,434
- Market cap
- ₹13,416 cr
- Stock P/E
- 38.4
- Book value
- ₹361
- ROE
- 26.0%
- ROCE
- 22.3%
- Dividend yield
- 0.29%
- 52w high / low
- 3785/2406
Metrics as of 6 Oct 2026. Not real time.
Track Privi Speciality Chemicals Ltd
Cruxal reads every Privi Speciality Chemicals Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Privi Speciality Chemicals Ltd growth and returns
- 10 Years
- %
- 5 Years
- 15%
- 3 Years
- 17%
- TTM
- 22%
- 10 Years
- %
- 5 Years
- 27%
- 3 Years
- 144%
- TTM
- 61%
- 10 Years
- 24%
- 5 Years
- 13%
- 3 Years
- 42%
- 1 Year
- 42%
- 10 Years
- 15%
- 5 Years
- 15%
- 3 Years
- 19%
- Last Year
- 26%
Privi Speciality Chemicals Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹666 cr, up 19.1% from ₹559 cr a year earlier. Net profit was ₹83 cr, up 43.1% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 533 | 491 | 614 | 559 | 679 | 605 | 722 | 666 |
| Expenses | 423 | 378 | 481 | 427 | 497 | 453 | 541 | 514 |
| Operating profit | 110 | 113 | 133 | 132 | 182 | 151 | 180 | 152 |
| OPM % | 21% | 23% | 22% | 24% | 27% | 25% | 25% | 23% |
| Other income | 4 | 2 | 15 | 9 | 0 | 7 | 4 | 15 |
| Interest | 22 | 22 | 23 | 24 | 21 | 19 | 18 | 17 |
| Depreciation | 32 | 32 | 35 | 36 | 36 | 36 | 36 | 37 |
| Profit before tax | 61 | 61 | 90 | 81 | 125 | 104 | 130 | 113 |
| Tax % | 26% | 27% | 29% | 29% | 28% | 28% | 27% | 27% |
| Net profit | 45 | 44 | 64 | 58 | 90 | 75 | 94 | 83 |
| EPS (₹) | 11.42 | 11.37 | 17.01 | 15.84 | 24.02 | 19.95 | 23.96 | 21.54 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Privi Speciality Chemicals Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 597 | 1,024 | 1,341 | 1,631 | 1,277 | 1,404 | 1,608 | 1,752 | 2,101 | 2,564 | 2,671 |
| Operating profit | 72 | 130 | 213 | 268 | 210 | 195 | 188 | 329 | 458 | 651 | 666 |
| OPM % | 12% | 13% | 16% | 16% | 16% | 14% | 12% | 19% | 22% | 25% | 25% |
| Net profit | 27 | 53 | 94 | 176 | 117 | 97 | 21 | 95 | 185 | 317 | 342 |
| EPS (₹) | 7.21 | 14.19 | 24.10 | 45.10 | 29.90 | 24.91 | 5.68 | 24.27 | 47.83 | 83.77 | 89.47 |
TTM is the trailing twelve months to the most recent quarter.
Privi Speciality Chemicals Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 38 | 38 | 39 | 39 | 39 | 39 | 39 | 39 | 39 | 39 |
| Reserves | 406 | 451 | 537 | 702 | 683 | 773 | 790 | 885 | 1,064 | 1,373 |
| Borrowings | 321 | 330 | 491 | 569 | 537 | 933 | 1,079 | 1,008 | 1,143 | 1,021 |
| Other liabilities | 174 | 235 | 359 | 294 | 281 | 431 | 483 | 410 | 544 | 736 |
| Total liabilities | 939 | 1,053 | 1,426 | 1,604 | 1,540 | 2,176 | 2,391 | 2,343 | 2,791 | 3,170 |
| Fixed assets | 388 | 437 | 498 | 725 | 598 | 704 | 1,017 | 1,034 | 1,156 | 1,169 |
| CWIP | 24 | 49 | 95 | 40 | 175 | 373 | 100 | 99 | 141 | 314 |
| Investments | 1 | 3 | 0 | 1 | 0 | 12 | 7 | 40 | 8 | 54 |
| Other assets | 527 | 564 | 833 | 839 | 768 | 1,087 | 1,268 | 1,169 | 1,485 | 1,633 |
| Total assets | 939 | 1,053 | 1,426 | 1,604 | 1,540 | 2,176 | 2,391 | 2,343 | 2,791 | 3,170 |
As reported by the company. Total assets equal total liabilities by construction.
Privi Speciality Chemicals Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 17 | 107 | 21 | 247 | 172 | 5 | 49 | 354 | 281 | 550 |
| Cash from investing | 80 | -81 | -139 | -206 | -242 | -321 | -133 | -180 | -294 | -358 |
| Cash from financing | -89 | -20 | 122 | 27 | 0 | 333 | 72 | -171 | 39 | -198 |
| Net cash flow | 7 | 5 | 4 | 68 | -69 | 17 | -12 | 4 | 26 | -6 |
| Free cash flow | 17 | 107 | 46 | 37 | -71 | -304 | -91 | 212 | -17 | 230 |
| CFO / operating profit | 49% | 96% | 24% | 120% | 101% | 19% | 33% | 116% | 77% | 102% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Privi Speciality Chemicals Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | — | 13% | 18% | 20% | 12% | 10% | 6% | 12% | 16% | 22% |
| Debtor days | 106 | 82 | 90 | 60 | 68 | 69 | 67 | 72 | 68 | 75 |
| Inventory days | 236 | 132 | 162 | 135 | 170 | 279 | 311 | 245 | 262 | 235 |
| Days payable | 115 | 85 | 95 | 55 | 83 | 138 | 114 | 105 | 134 | 150 |
| Cash conversion cycle | 227 | 129 | 157 | 139 | 155 | 209 | 264 | 212 | 197 | 160 |
| Working capital days | 31 | 20 | 40 | 45 | 65 | 19 | 16 | 37 | 35 | 54 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Privi Speciality Chemicals Ltd shareholding pattern
Promoters held 60.60% at Jun 2026, down from 69.89% at Jun 2025. FIIs 1.94% and DIIs 10.07%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 74.05% | 74.05% | 74.05% | 69.89% | 69.89% | 60.60% | 60.60% | 60.60% |
| FIIs | 0.43% | 0.48% | 0.40% | 1.47% | 1.33% | 1.64% | 1.37% | 1.94% |
| DIIs | 2.49% | 2.09% | 1.95% | 3.90% | 4.55% | 10.25% | 10.67% | 10.07% |
| Public | 23.02% | 23.38% | 23.62% | 24.73% | 24.24% | 27.51% | 27.36% | 27.39% |
| No. of shareholders | 16,372 | 18,131 | 16,721 | 28,685 | 28,203 | 32,016 | 34,415 | 44,875 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Upcoming Privi Speciality Chemicals Ltd events
The next scheduled event is a merger acquisition on 27 Oct 2026.
- Merger acquisitionMeeting of equity shareholders to consider and approve the Scheme of Amalgamation of Privi Fine Sciences Private Limited and Privi Biotechnologies Private Limited with Privi Speciality Chemicals Limited
- EGMMeeting of equity shareholders to consider and approve the Scheme of Amalgamation of Privi Fine Sciences Private Limited and Privi Biotechnologies Private Limited with Privi Speciality Chemicals Limited.
See the full results calendar for every Indian company reporting in the next 30 days.
Privi Speciality Chemicals Ltd corporate filings
- Certificate under Reg 74(5) of SEBI (DP) Regulations for the quarter ended September 30, 2026.Company Updatelow impact
- Company's Scheme of Amalgamation aims to create operational synergies, optimize resource utilization, and strengthen market position through strategic integration of subsidiaries and related entities.Company Updatehigh impact
Cruxal's analysis: Privi Speciality Chemicals Limited is executing a comprehensive Scheme of Amalgamation…
Read the full analysis - Privi Speciality Chemicals Limited: SBI Mutual Fund reduces stake by 0.0471% via open market saleInsider Trading / SASTlow impact
Cruxal's analysis: Privi Speciality Chemicals Limited has reported a minor reduction in shareholding by SBI…
Read the full analysis - Privi Speciality Chemicals Limited Announces NCLT-Convened Meeting of Equity Shareholders for Scheme of AmalgamationCompany Updatemedium impact
Cruxal's analysis: Privi Speciality Chemicals Limited has announced that, pursuant to an order from the…
Read the full analysis - Privi Speciality Chemicals Limited Announces NCLT-Convened Meeting for Amalgamation SchemeAGM/EGMhigh impact
Cruxal's analysis: Privi Speciality Chemicals Limited has announced a meeting of its equity shareholders…
Read the full analysis - Intimation of Closure of Trading Window for the second quarter and half year ending September 30,2026.Insider Trading / SASTlow impact
- Privi Speciality Chemicals Ltd schedules analyst and institutional investor meetingsCompany Updatelow impact
Cruxal's analysis: Privi Speciality Chemicals Ltd has issued an intimation regarding upcoming meetings with…
Read the full analysis - Privi Speciality Chemicals Ltd schedules analyst/institutional investor meeting for August 18, 2026Company Updatelow impact
Cruxal's analysis: Privi Speciality Chemicals Ltd has announced a scheduled meeting with analysts and…
Read the full analysis - Privi Speciality Chemicals Limited concludes 41st AGM with shareholder approval for final dividend of INR 10 per shareAGM/EGMlow impact
Cruxal's analysis: Privi Speciality Chemicals Limited has successfully concluded its 41st Annual General…
Read the full analysis - Privi Speciality Chemicals Limited concludes 41st AGM; declares final dividend of INR 10 per shareAGM/EGMlow impact
Cruxal's analysis: Privi Speciality Chemicals Limited has successfully concluded its 41st Annual General…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.